Skip to main content
. 2020 Nov 10;14:4815–4824. doi: 10.2147/DDDT.S276704

Figure 3.

Figure 3

(A) Substrate saturation plots, from product formation data, for venlafaxine (1–200 µM) in RLMs. (B) Effect of the vonoprazan on venlafaxine metabolism in RLMs (vonoprazan 0.1–100 µM).